2005-2022年澳大利亚和新西兰重症监护病房急性低氧性呼吸衰竭的流行病学:一项基于登记系统的两国研究
该两国登记系统研究纳入2005-2022年澳大利亚和新西兰ICU收治的所有成人患者,要求入ICU 24小时内有动脉血气;AHRF定义为PaO2/FiO2≤300。在1,560,221例患者中,826,106例(52.9%)在入ICU 24小时内存在或发生AHRF,其中轻度(200-300)占51.4%、中度(100-200)占39.3%、重度(<100)占9.3%。院内死亡率:无AHRF 5.3%、轻度8%、中度14.2%、重度29.9%;调整后死亡率随PaO2/FiO2下降而进行性升高,拐点位于PaO2/FiO2=200。所有患者调整后院内死亡率从2005年13.3%降至2022年8.2%,有无AHRF患者趋势相似。作者认为AHRF的医疗负担可能被低估,重度AHRF死亡率仍高,死亡率下降可能反映ICU整体救治水平提高而非AHRF专项进步,需更多研究早期识别AHRF并分层恶化风险,并验证本研究结果。
要点
- 在1,560,221例成人ICU患者中,826,106例(52.9%)在入ICU 24小时内存在或发生AHRF(PaO2/FiO2≤300)。
- AHRF严重程度构成:轻度(200-300)51.4%、中度(100-200)39.3%、重度(<100)9.3%。
- 院内死亡率:无AHRF 5.3%、轻度8%、中度14.2%、重度29.9%。
- 调整后院内死亡率随PaO2/FiO2下降进行性升高,拐点位于PaO2/FiO2=200。
- 所有患者调整后院内死亡率从2005年13.3%降至2022年8.2%,有无AHRF趋势相似。
适用人群与场景
- 2005-2022年澳大利亚或新西兰ICU收治的所有成人患者,且入ICU 24小时内行动脉血气检查。
诊断标准与关键阈值
- AHRF定义:入ICU 24小时内动脉血气PaO2/FiO2≤300。
- 严重程度分级:轻度PaO2/FiO2 200-300,中度100-200,重度<100。
研究设计与关键结果
- 研究类型:两国、基于登记系统的研究,纳入2005-2022年澳大利亚和新西兰ICU的成人患者(共1,560,221例)。
- AHRF发生率:826,106例(52.9%)在入ICU 24小时内存在或发生AHRF。
- AHRF严重程度构成:轻度51.4%、中度39.3%、重度9.3%。
- 院内死亡率:无AHRF 5.3%、轻度AHRF 8%、中度AHRF 14.2%、重度AHRF 29.9%。
- 调整后院内死亡率随PaO2/FiO2下降进行性升高,拐点位于PaO2/FiO2=200。
- 所有患者调整后院内死亡率从2005年13.3%降至2022年8.2%,有无AHRF患者趋势相似。
证据类型、等级与局限
- 证据类型:基于登记系统的观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为AHRF的医疗负担可能比预期更大,重度AHRF死亡率仍高。
- 作者认为死亡率随时间下降可能反映ICU整体救治水平提高,而非AHRF专项进步。
- 作者认为需更多研究以早期识别AHRF、早期分层恶化风险并验证本研究结果。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Acute hypoxaemic respiratory failure (AHRF) is a common reason for intensive care unit (ICU) admission. However, patient characteristics, outcomes, and trends over time are unclear. We describe the epidemiology and outcomes of patients with AHRF over time.
METHODS: In this binational, registry-based study from 2005 to 2022, we included all adults admitted to an Australian or New Zealand ICU with an arterial blood gas within the first 24 h of ICU stay. AHRF was defined as a partial pressure of oxygen/inspired oxygen ratio (PaO2/FiO2) ≤ 300. The primary outcome was adjusted in-hospital mortality, categorised based on PaO2/FiO2 (mild: 200-300, moderate: 100-200, and severe < 100, and non-linearly). We investigated how adjusted mortality evolved based on temporal trends (by year of admission), sex, age, admission diagnosis and the receipt of mechanical ventilation.
RESULTS: Of 1,560,221 patients, 826,106 (52.9%) were admitted with or developed AHRF within the first 24 h of ICU stay. Of these 826,106 patients, 51.4% had mild, 39.3% had moderate, and 9.3% had severe AHRF. Compared to patients without AHRF (5.3%), patients with mild (8%), moderate (14.2%) and severe (29.9%) AHRF had higher in-hospital mortality rates. As PaO2/FiO2 ratio decreased, adjusted in-hospital mortality progressively increased, particularly below an inflection point at a PaO2/FiO2 ratio of 200. The adjusted in-hospital mortality for all patients decreased over time (13.3% in 2005 to 8.2% in 2022), and this trend was similar in patients with and without AHRF.
CONCLUSION: The healthcare burden due to AHRF may be larger than expected, and mortality rates remain high in severe AHRF. Although mortality has decreased over time, this may reflect improvements in ICU care in general, rather than specifically in AHRF. More research is required to earlier identify AHRF and stratify these patients at risk of deterioration early, and to validate our findings.
参考来源
- Ling RR, Ponnapa Reddy M, Subramaniam A, et al. Epidemiology of acute hypoxaemic respiratory failure in Australian and New Zealand intensive care units during 2005-2022. A binational, registry-based study. Intensive Care Med. 2024. PMID: 39222135. doi:10.1007/s00134-024-07609-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。